Chiome Bioscience's revenue for the
three
months ended in Mar. 2024 was 円129.6 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円642.7 Mil.
Chiome Bioscience's Revenue per Share for the
three
months ended in Mar. 2024 was 円2.39.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円12.57.
Warning Sign:
Chiome Bioscience Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Chiome Bioscience was -12.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 0.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Chiome Bioscience's highest 3-Year average Revenue per Share Growth Rate was 30.60% per year. The lowest was -33.40% per year. And the median was -7.10% per year.
Chiome Bioscience Revenue Historical Data
The historical data trend for Chiome Bioscience's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chiome Bioscience's Revenue
For the Biotechnology subindustry, Chiome Bioscience's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiome Bioscience's Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Revenue distribution charts can be found below:
* The bar in red indicates where Chiome Bioscience's Revenue falls into.
Chiome Bioscience Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円642.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiome Bioscience (TSE:4583) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Chiome Bioscience Revenue Related Terms
Thank you for viewing the detailed overview of Chiome Bioscience's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4583 has been successfully added to your 